A meta-analysis of incident MACE in the Phase III tirzepatide clinical trial programme for type 2 diabetes revealed evidence for cardiovascular safety and numerically fewer MACE events in people randomised to tirzepatide therapy [126]
Suggested Use Initial use for the first week, take 1/2 a lozenge by mouth, let dissolve slowly, then swallow
For longer-term storage, aliquot and freeze at 20 C or below
The safest approach is individualized care guided by a licensed medical provider familiar with both wellness therapies and overall patient health. For patients exploring recovery-focused wellness support, the safest approach is working with a licensed provider familiar with both peptide wellness therapies and GLP-1-based medical weight loss care
So stick with me and lets get into it
Professional liability considerations are important, as the use of non-FDA approved compounds may carry different legal risks compared to approved medications